Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPLACE: Fibrinogen Concentrate vs Placebo in Complex Cardiovascular Surgery
2011-002685-20Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Not applicable and periprocedural bleeding comparing Fibrinogen concentrate (FCH) with Placebo (2 arms). Primary endpoint: Allogeneic blood product transfusion within 24 hours. Started Aug 2011; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
Not applicableperiprocedural bleeding
Beyond the preview
Go deeper on 2011-002685-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002685-20.